Glycyrrhizin and licorice significantly affect the pharmacokinetics of methotrexate in rats

Journal of Agricultural and Food Chemistry

Volumn 57, Issue 5, 2009, Pages 1854-1859

  Lin, Shiuan Pey ^a   Tsai, Shang Yuan ^a   Hou, Yu Chi ^a   Chao, Pei Dawn Lee ^b  

^a Graduate Institute of Pharmaceutical Chemistry   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Glycyrrhetic acid; Glycyrrhizin; Interaction; Licorice; Methotrexate pharmacokinetics

Indexed keywords

GLYCYRRHETINIC ACID; GLYCYRRHIZIC ACID; METHOTREXATE; PLANT EXTRACT;

ANIMAL; ARTICLE; BLOOD; CHEMISTRY; DRUG INTERACTION; GLYCYRRHIZA; MALE; METABOLISM; ORAL DRUG ADMINISTRATION; RAT; SPRAGUE DAWLEY RAT;

ADMINISTRATION, ORAL; ANIMALS; DRUG INTERACTIONS; GLYCYRRHETINIC ACID; GLYCYRRHIZA; GLYCYRRHIZIC ACID; MALE; METHOTREXATE; PLANT EXTRACTS; RATS; RATS, SPRAGUE-DAWLEY;

GLYCYRRHIZA; GLYCYRRHIZA URALENSIS; RATTUS;

EID: 64549144622     PISSN: 00218561     EISSN: None     Source Type: Journal    
DOI: 10.1021/jf8029918     Document Type: Article

References (31)

1. Aly, A. M.; Al-Alousi, L.; Salem, H. A. Licorice: a possible antiinflammatory and anti-ulcer drug. AAPS PharmSciTech 2005, 6, E74-82.
2. Fiore, C.; Eisenhut, M.; Krausse, R.; Ragazzi, E.; Pellati, D.; Armanini, D.; Bielenberg, J. Antiviral effects of Glycyrrhiza species. Phytother. Res. 2007, 22, 141-148.
3. Stickel, F.; Schuppan, D. Herbal medicine in the treatment of liver diseases. Dig. Liver Dis. 2007, 39, 293-304.
4. Yuan, H.; Ji, W. S.; Wu, K. X.; Jiao, J. X.; Sun, L. H.; Feng, Y. T. Anti-inflammatory effect of diammonium glycyrrhizinate in a rat model of ulcerative colitis. World J. Gastroenterol. 2006, 12, 4578-4581.
5. Sato, H.; Goto, W.; Yamamura, J.; Kurokawa, M.; Kageyama, S.; Takahara, T.; Watanabe, A.; Shiraki, K. Therapeutic basis of glycyrrhizin on chronic hepatitis B. Antiviral Res. 1996, 30, 171-177.
6. Cinatl, J.; Morgenstern, B.; Bauer, G.; Chandra, P.; Rabenau, H.; Doerr, H. W. Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus. Lancet 2003, 361, 2045-2046.
7. Evans, W. E.; Crom, W. R.; Abromowitch, M.; Dodge, R.; Look, A. T.; Bowman, W. P.; George, S. L.; Pui, C. H. Clinical pharmacodynamics of high-dose methotrexate in acute lymphocytic leukemia. Identification of a relation between concentration and effect. N. Engl. J. Med. 1986, 314, 471-477.
8. Tishler, M.; Caspi, D.; Yaron, M. Long-term experience with low dose methotrexate in rheumatoid arthritis. Rheumatol. Int. 1993, 13, 103-106.
9. Chladek, J.; Grim, J.; Martinkova, J.; Simkova, M.; Vaneckova, J. Low-dose methotrexate pharmacokinetics and pharmacodynamics in the therapy of severe psoriasis. Basic Clin. Pharmacol. Toxicol. 2005, 96, 247-248.
10. Kuijpers, A. L.; van de Kerkhof, P. C. Risk-benefit assessment of methotrexate in the treatment of severe psoriasis. Am. J. Clin. Dermatol. 2000, 1, 27-39.
11. Carneiro-Filho, B. A.; Lima, I. P.; Araujo, D. H.; Cavalcante, M. C.; Carvalho, G. H.; Brito, G. A.; Lima, V.; Monteiro, S. M.; Santos, F. N.; Ribeiro, R. A.; Lima, A. A. Intestinal barrier function and secretion in methotrexate-induced rat intestinal mucositis. Dig. Dis. Sci. 2004, 49, 65-72.
12. Thyss, A.; Milano, G.; Kubar, J.; Namer, M.; Schneider, M. Clinical and pharmacokinetic evidence of a life-threatening interaction between methotrexate and ketoprofen. Lancet 1986, 1, 256-258.
13. Singh, R. R.; Malaviya, A. N.; Pandey, J. N.; Guleria, J. S. Fatal interaction between methotrexate and naproxen. Lancet 1986, 1, 1390.
14. Takeda, M.; Khamdang, S.; Narikawa, S.; Kimura, H.; Hosoyamada, M.; Cha, S. H.; Sekine, T.; Endou, H. Characterization of methotrexate transport and its drug interactions with human organic anion transporters. J. Pharmacol. Exp. Ther. 2002, 302, 666-671.
15. Hulot, J. S.; Villard, E.; Maguy, A.; Morel, V.; Mir, L.; Tostivint, I.; William-Faltaos, D.; Fernandez, C.; Hatem, S.; Deray, G.; Komajda, M.; Leblond, V.; Lechat, P. A mutation in the drug transporter gene ABCC2 associated with impaired methotrexate elimination. Pharmacogenet. Genomics 2005, 15, 277-285.
16. Nozaki, Y.; Kusuhara, H.; Kondo, T.; Iwaki, M.; Shiroyanagi, Y.; Nakayama, H.; Horita, S.; Nakazawa, H.; Okano, T.; Sugiyama, Y. Species difference in the inhibitory effect of nonsteroidal anti-inflammatory drugs on the uptake of methotrexate by human kidney slices. J. Pharmacol. Exp. Ther. 2007, 322, 1162-1170.
17. Horikawa, M.; Kato, Y.; Tyson, C. A.; Sugiyama, Y. The potential for an interaction between MRP2 (ABCC2) and various therapeutic agents: probenecid as a candidate inhibitor of the biliary excretion of irinotecan metabolites. Drug Metab. Pharmacokinet. 2002, 17, 23-33.
18. Wang, Z.; Kurosaki, Y.; Nakayama, T.; Kimura, T. Mechanism of gastrointestinal absorption of glycyrrhizin in rats. Biol. Pharm. Bull. 1994, 17, 1399-1403.
19. Takeda, S.; Ishthara, K.; Wakui, Y.; Amagaya, S.; Maruno, M.; Akao, T.; Kobashi, K. Bioavailability study of glycyrrhetic acid after oral administration of glycyrrhizin in rats; relevance to the intestinal bacterial hydrolysis. J. Pharm. Pharmacol. 1996, 48, 902-905.
20. Ching, H.; Hsiu, S. L.; Hou, Y. C.; Chen, C. C.; Chao, P. D. Comparison of pharmacokinetics between glycyrrhizin and glycyrrhetic acid in rabbits. J. Food Drug Anal. 2001, 9, 67-71.
21. Hou, Y. C.; Hsiu, S. L.; Ching, H.; Lin, Y. T.; Tsai, S. Y.; Wen, K. C.; Chao, P. D. Profound difference of metabolic pharmacokinetics between pure glycyrrhizin and glycyrrhizin in licorice decoction. Life Sci. 2005, 76, 1167-1176.
22. Yoshida, N.; Takada, T.; Yamamura, Y.; Adachi, I.; Suzuki, H.; Kawakami, J. Inhibitory effects of terpenoids on multidrug resistance-associated protein 2- and breast cancer resistance protein-mediated transport. Drug Metab. Dispos. 2008, 36, 1206-1211.
23. Galivan, J. Evidence for the cytotoxic activity of polyglutamate derivatives of methotrexate. Mol. Pharmacol. 1980, 17, 105-110.
24. Jolivet, J.; Schilsky, R. L.; Bailey, B. D.; Drake, J. C.; Chabner, B. A. Synthesis, retention, and biological activity of methotrexate polyglutamates in cultured human breast cancer cells. J. Clin. Invest. 1982, 70, 351-360.
25. Ploeger, B.; Mensinga, T.; Sips, A.; Meulenbelt, J.; DeJongh, J. A human physiologically-based model for glycyrrhzic acid, a compound subject to presystemic metabolism and enterohepatic cycling. Pharm. Res. 2000, 17, 1516-1525.
26. Manach, C.; Donovan, J. L. Pharmacokinetics and metabolism of dietary flavonoids in humans. Free Radical Res. 2004, 38, 771-785.
27. Walle, T. Absorption and metabolism of flavonoids. Free Radical Biol. Med. 2004, 36, 829-837.
28. Jo, E. H.; Hong, H. D.; Ahn, N. C.; Jung, J. W.; Yang, S. R.; Park, J. S.; Kim, S. H.; Lee, Y. S.; Kang, K. S. Modulations of the Bcl-2/Bax family were involved in the chemopreventive effects of licorice root (Glycyrrhiza uralensis Fisch) in MCF-7 human breast cancer cell. J. Agric. Food Chem. 2004, 52, 1715-1719.
29. Anzai, N.; Kanai, Y.; Endou, H. Organic anion transporter family: current knowledge. J. Pharmacol. Sci. 2006, 100, 411-426.
30. Blanchard, J.; Boyle, J. O.; Van Wagenen, S. Determination of the partition coefficients, acid dissociation constants, and intrinsic solubility of carbenoxolone. J. Pharm. Sci. 1988, 77, 548-552.
31. Su, X.; Lawrence, H.; Ganeshapillai, D.; Cruttenden, A.; Purohit, A.; Reed, M. J.; Vicker, N.; Potter, B. V. Novel 18-glycyrrhetinic acid analogues as potent and selective inhibitors of 11-hydroxysteroid dehydrogenases. Bioorg. Med. Chem. 2004, 12, 4439-4457.